Stella Diagnostics (Stella Diagnostics) Current Accrued Expense : $5.58 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Stella Diagnostics Current Accrued Expense?

Stella Diagnostics's Current Accrued Expense for the quarter that ended in Sep. 2023 was $5.58 Mil.

Stella Diagnostics's quarterly Current Accrued Expense stayed the same from . 20 ($0.00 Mil) to Sep. 2022 ($0.00 Mil) but then increased from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($5.58 Mil).

Stella Diagnostics Current Accrued Expense Historical Data

The historical data trend for Stella Diagnostics's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Diagnostics Current Accrued Expense Chart

Stella Diagnostics Annual Data

Trend

Current Accrued Expense

Stella Diagnostics Quarterly Data
	Sep22	Sep23
Current Accrued Expense	-	5.58

Stella Diagnostics Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Stella Diagnostics Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Stella Diagnostics's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Diagnostics (Stella Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Stella Diagnostics Inc (OTCPK:SLDX) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 West Broadway, Suite 300, Salt Lake City, UT, USA, 84104

Website

https://www.stelladx.com

Stella Diagnostics Inc is a molecular diagnostics-based organization focused on improving patient management strategies for people living with severe esophageal disease. It is developing first-line diagnostic tools that provide superior molecular information for providers as compared to the current standard screening protocols.